International Network Launched to Support Childhood Cancer Care in Uzbekistan

An international network to support children with serious and life-threatening illnesses, including cancer, was announced in Samarkand on October 21. The new initiative will bring together first ladies and spouses of heads of state. The network's establishment was announced by Carlos Rodriguez-Galindo, executive vice president of St. Jude Children's Research Hospital in the United States and director of St. Jude Global, which works to improve childhood cancer care worldwide. Uzbekistan's First Lady Ziroat Mirziyoyeva was named chair for a two-year term. Participants in the initiative intend to share expertise and help expand children's access to diagnosis, treatment, and quality medical care. The announcement came during the second International Congress on Pediatric Oncology, held on October 21–22 alongside the World Summit on Children's Well-Being. The events brought together representatives from more than 100 countries, international organizations, and the medical community. Summit partners include UNICEF, the World Health Organization (WHO), and the World Bank. Mirziyoyeva also chairs the board of trustees of the Zamin Foundation, which co-hosted a UN event with St. Jude and the WHO in September 2025 aimed at improving survival rates among children with cancer and other serious illnesses. Uzbekistan is already participating in an international program to improve access to childhood cancer treatments. In February 2025, Uzbekistan and Mongolia became the first two countries to receive essential cancer medicines through a WHO–St. Jude initiative. The program aims to provide children in lower-income countries with a reliable supply of quality-assured cancer medicines free of charge. Uzbekistan is also preparing changes to its national cancer care system. As The Times of Central Asia previously reported, the country plans to reform its oncology services beginning in 2027, while a pediatric palliative care center is planned for the Samarkand region to support children with serious and incurable illnesses.

Tajikistan Shuts Down Counterfeit Children’s Medicines Operation

Law enforcement authorities in Dushanbe have shut down an underground operation that allegedly produced counterfeit pharmaceutical products, including medicines intended for children. According to the Dushanbe police department, the seized products included syrups sold under well-known brands including Nurofen, Paracetamol, Lazolvan, Theraflu, and others. Authorities said the products were manufactured in unsanitary conditions and distributed with falsified branding. During searches, police confiscated around 35,900 bottles of syrup, more than 405,000 packages and labels, over 600 kilograms of raw materials, and equipment allegedly used in the production process. A 42-year-old Dushanbe resident, Otabek Dadachonov, has been detained on suspicion of organizing the illegal operation. The Interior Ministry said he had previously been convicted of several economic crimes. Several alleged accomplices were also detained and are accused of helping produce packaging and distribute the counterfeit medicines. Investigators said the group operated through officially registered companies but did not have the licenses required to carry out pharmaceutical activity. Dushanbe police warned that the distribution of such counterfeit medicines could pose a serious threat to public health, especially for children. A criminal case has been opened under several articles of Tajikistan’s Criminal Code. The investigation is ongoing.